Cristiana Vignoli, CEO of Hemera, has been appointed Sole Director of Proemera, the main investment vehicle supporting Hemera since its foundation.
The appointment strengthens the strategic link between the two organizations and helps ensure continuity of vision and guidance in the company’s development. In her new role, Cristiana Vignoli will continue to work to enhance investments in research and innovation, supporting the growth of Hemera and its projects.
This step consolidates governance and supports Hemera’s expansion in the biotechnology and regenerative medicine landscape at a key stage of its journey.
Hemera wishes her every success in this new role!